Upstream Assets and Investment Strategies with Sa'ad Shah
Similar Posts
Interview with Ed Prideaux, Journalist at the Perception Restoration Foundation
In this episode, journalist Ed Prideaux discusses Hallucinogen Persisting Perception Disorder and some of the other very real risks involved with psychedelic misuse.
SPOTLIGHT IN FOCUS – The Rise of Psychedelic Therapy
Dr. Zinia Thomas at Radiance Wellness, St. Louis MO –…
Riley Cote – From NHL Enforcer to Psychedelic Therapy Advocate
On this episode of the Psychedelic Spotlight Podcast, our host David Flores catches up with former Philadelphia Flyer and NHL enforcer, Riley Cote who in recent years has become one of the most prominent and outspoken advocates for psychedelics and psychedelic-assisted therapy through his work with the Wake Network and RileyCote.com.
Interview With Anthony Tennyson
We speak with Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction.
Medical Applications of Ketamine & Common Misconceptions with Christi Myers, Flow Integrative
In this episode, Christi provides insight into how ketamine impacts people’s physical and mental health. She goes into the comparison of ketamine’s effects compared to other psychedelics and how Flow Integrative’s patient care is unique.
Psychedelic Business Spotlight: June 4, 2021
This week in psychedelic business: Mindset Pharma’s new research, synthetic ibogaine, and the Western Hemisphere gets its first “smart shop.”